Claritas Pharmaceuticals

Board Description

Claritas Pharmaceuticals is developing R-107, a nitric oxide-releasing molecule designed to treat vaccine-resistant COVID-19 infection.

Industry
Pharmaceuticals
Country
United States
State
California
Stock Market
TSX
Stock Ticker
KLY
Ranking
N/A